Insulin supply and localization of production: Malaysia’s case.
103 years after its discovery, insulin is reinventing itself: from pricing readjustments in major markets to the increasing usage of biosimilars. Historic players like Novo Nordisk and Eli Lilly seek growth outside insulin, with successes notably in obesity management drugs […]